98 related articles for article (PubMed ID: 20846263)
61. HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target.
Fan F; Mo H; Zhang H; Dai Z; Wang Z; Qu C; Liu F; Zhang L; Luo P; Zhang J; Liu Z; Cheng Q; Ding F
Biomed Pharmacother; 2022 Nov; 155():113800. PubMed ID: 36271576
[TBL] [Abstract][Full Text] [Related]
62. Association of leucine zipper protein 2 with prognosis and epigenetic modification in patients with renal clear-cell carcinoma.
Shi X; Li L; Feng D; Wei W
Asian J Surg; 2023 May; 46(5):1993-1997. PubMed ID: 36379756
[No Abstract] [Full Text] [Related]
63. Correction: CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug.
Liang Y; Cen J; Huang Y; Fang Y; Wang Y; Shu G; Pan Y; Huang K; Dong J; Zhou M; Xu Y; Luo J; Liu M; Zhang J
Mol Cancer; 2023 Jan; 22(1):14. PubMed ID: 36670419
[No Abstract] [Full Text] [Related]
64. Prognostic stratification of renal cell carcinoma using a pathological triad of microvascular invasion, Fuhrman's grade and tumor size.
Prakash G; Gautam G
Indian J Urol; 2007 Oct; 23(4):482-3. PubMed ID: 19718313
[No Abstract] [Full Text] [Related]
65. Four methylation-driven genes may be prognostic biomarkers in clear cell renal carcinoma.
Yin H; Zhang H; Wang X; Xu Q
Clin Transl Med; 2020 Jun; 10(2):e45. PubMed ID: 32508031
[No Abstract] [Full Text] [Related]
66. Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
Shenoy N
Chin J Cancer Res; 2017 Apr; 29(2):166-167. PubMed ID: 28536496
[No Abstract] [Full Text] [Related]
67. Clinical Significance of
Kubiliute R; Zalimas A; Bakavicius A; Ulys A; Jankevicius F; Jarmalaite S
Onco Targets Ther; 2021; 14():4979-4990. PubMed ID: 34675538
[TBL] [Abstract][Full Text] [Related]
68. HOXA5 Is Recognized as a Prognostic-Related Biomarker and Promotes Glioma Progression Through Affecting Cell Cycle.
Ding F; Chen P; Bie P; Piao W; Cheng Q
Front Oncol; 2021; 11():633430. PubMed ID: 34485110
[TBL] [Abstract][Full Text] [Related]
69. An aging and p53 related marker:
Feiner LK; Tierling S; Holländer S; Glanemann M; Rubie C
Aging (Albany NY); 2021 Feb; 13(4):4831-4849. PubMed ID: 33547267
[TBL] [Abstract][Full Text] [Related]
70. Methylation in
Paço A; de Bessa Garcia SA; Freitas R
Cells; 2020 Jul; 9(7):. PubMed ID: 32635388
[No Abstract] [Full Text] [Related]
71. HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer.
Chang CJ; Chen YL; Hsieh CH; Liu YJ; Yu SL; Chen JJW; Wang CC
J Cancer; 2017; 8(6):1071-1081. PubMed ID: 28529621
[TBL] [Abstract][Full Text] [Related]
72. miR-429 mediates tumor growth and metastasis in colorectal cancer.
Han Y; Zhao Q; Zhou J; Shi R
Am J Cancer Res; 2017; 7(2):218-233. PubMed ID: 28337372
[TBL] [Abstract][Full Text] [Related]
73. The epigenetic landscape of clear-cell renal cell carcinoma.
Kluzek K; Bluyssen HA; Wesoly J
J Kidney Cancer VHL; 2015; 2(3):90-104. PubMed ID: 28326264
[TBL] [Abstract][Full Text] [Related]
74. Role of DNA methylation in renal cell carcinoma.
Shenoy N; Vallumsetla N; Zou Y; Galeas JN; Shrivastava M; Hu C; Susztak K; Verma A
J Hematol Oncol; 2015 Jul; 8():88. PubMed ID: 26198328
[TBL] [Abstract][Full Text] [Related]
75. Expression of CC chemokine receptor 5 in clear cell renal cell carcinoma and its clinical significance.
Yoo KH; Lee DG; Won KY; Lim SJ; Park YK; Chang SG
Oncol Lett; 2015 May; 9(5):2085-2089. PubMed ID: 26137017
[TBL] [Abstract][Full Text] [Related]
76. HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer.
Zhang ML; Nie FQ; Sun M; Xia R; Xie M; Lu KH; Li W
Tumour Biol; 2015 May; 36(5):3521-31. PubMed ID: 25549794
[TBL] [Abstract][Full Text] [Related]
77. Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma.
Yoo KH; Won KY; Lim SJ; Park YK; Chang SG
Oncol Lett; 2014 Nov; 8(5):2135-2139. PubMed ID: 25295100
[TBL] [Abstract][Full Text] [Related]
78. DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma.
Yoo KH; Park YK; Chang SG
Oncol Lett; 2013 Jan; 5(1):39-42. PubMed ID: 23255890
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
